2022 annual financial data
Outlook Therapeutics 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -63,071,000 USD and net income was -66,052,000 USD.
Operating cash flow was Not available.
Get free Outlook Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -63,071,000 USD
- Net income
- -66,052,000 USD
- Operating cash flow
- Not available